Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S056 - Advanced Medical Dermatology

Monday, February 19; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize classic and unusual presentations of medical dermatological diseases
  • Evaluate patients with skin signs of systemic disease for systemic involvement
  • Develop treatment strategies for complex medical dermatological diagnoses

Description

In this session faculty (established experts and rising stars) from across the country will discuss key, new, and emerging concepts across the spectrum of "Advanced Medical Dermatology." Topics include calciphylaxis, connective tissue disease, drug reactions, chemotherapy reactions, lichenoid reaction, novel treatment approaches, cutaneous lymphoma and more.

Disclosures

  • Dominguez, Arturo R, MD: no financial relationships exist with commercial interests.
  • Fox, Lindy Peta, MD: no financial relationships exist with commercial interests.
  • Harp, Joanna L., MD: no financial relationships exist with commercial interests.
  • Haun, Paul, MD, MS: Health Press, Inc – O(IP);
  • Imadojemu, Sotonye, MD: no financial relationships exist with commercial interests.
  • Lacouture, Mario E., MD: AbbVie – C(H); ADC Therapeutics – C(H); Adgero Biopharmaceuticals Holdings, Inc. – C(H); Astellas Pharma US, Inc – C(H); Celldex – C(H); Galderma Research & Development, LLC – C(H); Helsinn Healthcare – C(H); Johnson and Johnson – C(H); Lindiskin – C(H); Menlo Therapeutics – C(H); Merck & Co., Inc – C(H); Novartis – C(H); Novocure – C(H);
  • Rosenbach, Misha, MD: Derm101 – Independent Contractor(H); Endocyte – I(NC); Gilead Sciences, Inc – I(Grants/Research Funding); GlaxoSmithKline – C(NC); Merck & Co., Inc – A(H); Promet Therapeutics, LLC – C(H);
  • Wetter, David A., MD: no financial relationships exist with commercial interests.
Schedule
Monday, February 19
1:05 PM
Dr. Dominguez / Calciphylaxis
1:30 PM
Dr. Imadojemu / Lichenoid dermatitidies
1:50 PM
Dr. Harp / TBD - (Severe drug eruptions)
2:20 PM
Dr. Fox / Approach to Urticaria When it Isn’t
2:45 PM
Dr. Wetter / Lenalidomide Treatment for Cutaneous Lupus
3:10 PM
Dr. Haun / Cutaneous Lymphomas
3:30 PM
Dr. Lacouture / Dermatologic Toxicities from Cancer Therapies
Event Details
  • Date
    Monday, February 19
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 1B
  • CME Credits
    3.00
  • Type
Directors/Co-Directors
  • Misha Rosenbach, MD, FAAD
Speakers
  • Arturo R Dominguez, MD, FAAD - Handout
  • David A. Wetter, MD, FAAD - Handout
  • Joanna L. Harp, MD, FAAD - Handout
  • Lindy Peta Fox, MD, FAAD
  • Mario E. Lacouture, MD, FAAD
  • Paul Haun, MD, MS, FAAD
  • Sotonye Imadojemu, MD, FAAD